Lilly antibody drug fails in a Covid-19 study; others go on
U.S. government officials are putting an early end to a study testing an Eli Lilly antibody drug for people hospitalized with Covid-19 because it doesn’t seem to be helping them.
U.S. government officials are putting an early end to a study testing an Eli Lilly antibody drug for people hospitalized with Covid-19 because it doesn’t seem to be helping them.